The prognostic significance of whole-body and spleen MTV (metabolic tumor volume) scanning for patients with diffuse large B cell lymphoma

被引:7
|
作者
Yamanaka, Shintaro [1 ]
Miyagawa, Masao [2 ]
Sugawara, Yoshifumi [3 ]
Hasebe, Shinji [4 ]
Fujii, Tomomi [4 ,5 ]
Takeuchi, Kazuto [4 ]
Tanaka, Keiko [6 ,7 ]
Yakushijin, Yoshihiro [4 ,5 ]
机构
[1] Ehime Univ, Sch Med, Toon, Ehime, Japan
[2] Ehime Univ, Grad Sch Med, Dept Radiol, Toon, Ehime, Japan
[3] Natl Hosp Org Shikoku Canc Ctr, Dept Diagnost Radiol, Matsuyama, Ehime, Japan
[4] Ehime Univ Hosp, Ctr Canc, Toon, Ehime, Japan
[5] Ehime Univ, Grad Sch Med, Dept Clin Oncol, Toon, Ehime 7910295, Japan
[6] Ehime Univ, Grad Sch Med, Dept Epidemiol & Prevent Med, Toon, Ehime, Japan
[7] Ehime Univ Hosp, Translat Res Ctr, Res Promot Unit, Toon, Ehime, Japan
关键词
SUV; MTV; 18F-FDG-PET; Diffuse large B cell lymphoma; FDG-PET/CT; FOLLICULAR LYMPHOMA; RESPONSE ASSESSMENT; POOLED ANALYSIS; PREDICTOR; THERAPY; INDEX;
D O I
10.1007/s10147-020-01807-6
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background Positron Emission Tomography-Computed Tomography (PET-CT) has been changing diagnostic and therapeutic strategies for patients with cancers, and several PET-CT-related prognostic factors have been reported. We have focused on metabolic tumor volumes (MTVs) over the whole body and in specific organs using 18F-PET-CT imaging, and have compared clinical data to know the prognosis of patients with diffuse large B cell lymphoma (DLBCL). Patients and methods From January 2006 to December 2016, patients who were newly diagnosed for de novo DLBCL and who received 18F-FDG PET-CT scans for disease staging at Ehime University Hospital were reviewed. Results A total of forty out of 108 patients with DLBCL were analyzed. The median and the average follow-up were 3.9 years and 3.6 years. Both MTV50 and MTV60 whole-body searching indicated effective prognostic values for patients with DLBCL statistically (P = 0.027). However, analysis of MTVs in the spleen and in bone marrow did not provide any prognostic value. Receiver operating characteristic (ROC) analysis indicated that the cutoff level 25.8 in MTV60 is the most effective prognostic value (P = 0.022) which predicts patient survival after treatment with R-CHOP chemotherapy. Conclusion MTV60 using whole-body scanning appears to be an effective indicator in DLBCL and indicates the patient prognosis.
引用
收藏
页码:225 / 232
页数:8
相关论文
共 50 条
  • [41] Prognostic significance of the red blood cell distribution width in diffuse large B-cell lymphoma patients
    Zhou, Shujuan
    Fang, Fang
    Chen, Huiyao
    Zhang, Wei
    Chen, Yang
    Shi, Yifen
    Zheng, Zhouyi
    Ma, Yongyong
    Tang, Liyuan
    Feng, Jianhua
    Zhang, Yu
    Sun, Lan
    Chen, Yi
    Liang, Bin
    Yu, Kang
    Jiang, Songfu
    ONCOTARGET, 2017, 8 (25) : 40724 - 40731
  • [42] Prognostic significance of CD30 expression in patients with diffuse large B-cell lymphoma
    Kanemasa, Yusuke
    Shimoyama, Tatsu
    Sasaki, Yuki
    Tamura, Miho
    Sawada, Takeshi
    Omuro, Yasushi
    Hishima, Tsunekazu
    Maeda, Yoshiharu
    ANNALS OF ONCOLOGY, 2017, 28
  • [43] Prognostic Significance of MiRNA in Patients with Diffuse Large B-Cell Lymphoma: a Meta-Analysis
    Zheng, Zhuojun
    Li, Xiaodong
    Zhu, Yuandong
    Gu, Weiying
    Xie, Xiaobao
    Jiang, Jingting
    CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2016, 39 (05) : 1891 - 1904
  • [44] Prognostic significance of the modified Barthel index in elderly patients with diffuse large B-cell lymphoma
    Ogura, Shinji
    Nakazato, Tomonori
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2020, 75 : 110 - 111
  • [45] Prognostic Significance of Blood Transfusion in Elderly Patients with Primary Diffuse Large B-Cell Lymphoma
    Fan, Liping
    Fu, Danhui
    Hong, Jinquan
    Huang, Haobo
    He, Wenqian
    Zeng, Feng
    Lin, Qiuyan
    Xie, Qianling
    BIOMED RESEARCH INTERNATIONAL, 2018, 2018
  • [46] Predictive and Prognostic Significance of Comprehensive Genomic Profiling in Patients with Diffuse Large B-Cell Lymphoma
    He, Jie
    Zhong, Shan
    Nahas, Michelle
    Bailey, Mark
    Chung, Jon
    Otto, Geoff
    Lipson, Doron
    Stephens, Phil
    Miller, Vincent A.
    Ross, Jeff
    Mughal, Tariq I.
    Vergilio, Jo-Anne
    BLOOD, 2015, 126 (23)
  • [47] Could blood groups have prognostic significance on survival in patients with diffuse large B cell lymphoma?
    Basci, Semih
    Bakirtas, Mehmet
    Batgi, Hikmetullah
    Yildiz, Jale
    Darcin, Tahir
    Sahin, Derya
    Iskender, Dicle
    Altuntas, Fevzi
    Ulu, Bahar Uncu
    Yigenoglu, Tugce Nur
    Baysal, Nuran Ahu
    Cakar, Merih Kizul
    Dal, Mehmet Sinan
    LEUKEMIA RESEARCH, 2022, 115
  • [48] MicroRNA Is Prognostic Indicator in Patients with Diffuse Large B Cell Lymphoma
    Lahav, Meir
    Ram, Ron
    Kushnir, Michal
    Spilberg, Ofer
    Yanai, Gila Lithwick
    Beeri, Osnat
    Hoshen, Moshe
    Feinmesser, Maora
    BLOOD, 2008, 112 (11) : 299 - 300
  • [49] THE PROGNOSTIC SIGNIFICANCE OF TUMOR-ASSOCIATED MACROPHAGES AND NK CELLS IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA TREATED WITH RCHOP
    Feng, Ru
    EXPERIMENTAL HEMATOLOGY, 2015, 43 (09) : S62 - S62
  • [50] The Prognostic Significance of Tumor-Associated Macrophages and NK Cells in Patients with Diffuse Large B-Cell Lymphoma Treated with RCHOP
    Xie, Muchen
    Wei, Yongqiang
    Yang, Lei
    Huang, Fen
    Wei, Xiaolei
    Jing, Hui
    Hao, Xiaoxiao
    Zeng, Hong
    Feng, Ru
    BLOOD, 2014, 124 (21)